Log In
Print
BCIQ
Print
Print this Print this
 

Allelock, olopatadine hydrochloride (KW-4679)

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionHistamine H1 receptor antagonist
Molecular Target Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAllergy
Indication DetailsTreat allergy; Treat pollinosis, allergic rhinitis and itching associated with chronic urticaria and skin diseases
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today